Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine

by Shigeki Watanabe, D. Scott Wilbur, Sujit Pal, Ming-Kuan Chyan, Ethan R. Balkin, Donald K. Hamlin, Katherine Gagnon
Published 2013-09-01

Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma

by Andrew D. Ludwig, Kevin P. Labadie, Y. David Seo, Donald K. Hamlin, Holly M. Nguyen, Vimukta M. Mahadev, Raymond S. Yeung, D. S. Wilbur, James O. Park
Published 2019-01-01

Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.

by Johnnie J Orozco, Ethan R Balkin, Ted A Gooley, Aimee Kenoyer, Donald K Hamlin, D Scott Wilbur, Darrell R Fisher, Mark D Hylarides, Mazyar Shadman, Damian J Green, Ajay K Gopal, Oliver W Press, John M Pagel
Published 2014-01-01

Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma

by Kevin P. Labadie, Andrew D. Ludwig, Adrienne L. Lehnert, Donald K. Hamlin, Aimee L. Kenoyer, Kevin M. Sullivan, Sara K. Daniel, Tara N. Mihailovic, Jonathan G. Sham, Johnnie J. Orozco, Raymond S. Yeung, Delphine L. Chen, D. Scott Wilbur, Robert S. Miyaoka, James O. Park
Published 2021-02-01

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies.

by Yawen Li, Donald K Hamlin, Ming-Kuan Chyan, Roger Wong, Eric F Dorman, Robert C Emery, Douglas R Woodle, Ronald L Manger, Margaret Nartea, Aimee L Kenoyer, Johnnie J Orozco, Damian J Green, Oliver W Press, Rainer Storb, Brenda M Sandmaier, D Scott Wilbur
Published 2018-01-01